文献速递内脏/肾动脉与血管畸形

症状性自发性孤立性肠系膜上动脉夹层的治疗策略与结局:系统综述与Meta分析

Treatment Strategies and Outcomes of Symptomatic Spontaneous Isolated Superior Mesenteric Artery Dissection: A Systematic Review and Meta-analysis.
PubMed 文献 · J Endovasc Ther · 2018-08-29

该系统综述与Meta分析纳入25篇文章共616例自发性孤立性肠系膜上动脉夹层(SISMAD),其中514例症状性病例可分析。保守治疗初始使用率87.0%,汇总成功率84.7%,转为介入率14.3%;抗血栓治疗组与未抗血栓组保守治疗失败率分别为17.8%和10.1%(p=0.103)。作者认为保守治疗在超过80%的症状性SISMAD病例中似乎安全有效,抗血栓药物使用未见明显获益。

要点

  • 症状性SISMAD初始保守治疗占87.0%,汇总成功率84.7%。
  • 保守治疗转为介入率14.3%,其中84%为腔内介入。
  • 抗血栓治疗组与未抗血栓组保守治疗失败率17.8% vs 10.1%(p=0.103)。

核心结论

  • 保守治疗在超过80%的症状性SISMAD病例中似乎安全有效,抗血栓药物使用未见明显获益。
  • 初始或二次干预更多采用腔内介入,成功率与短期结局良好。
  • 作者认为需开展大规模、前瞻性随机试验并进行长期随访以研究症状性SISMAD的治疗。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed和Cochrane数据库2007年1月至2018年1月发表的英文症状性SISMAD文献。
  • 纳入报告两种治疗方式及结局的病例系列,排除创伤性或医源性SMA夹层及伴主动脉或其他内脏动脉夹层的SMA夹层。
  • 共纳入25篇文章,涵盖616例SISMAD病例,其中514例症状性病例符合分析条件。

主要发现

  • 514例症状性病例中,初始保守治疗447例(87.0%),外科干预67例(13.0%),其中腔内介入45例(8.7%)、开放手术22例(4.3%)。
  • 保守治疗病例中,238例(53.2%)接受抗血栓治疗,172例(38.5%)未接受;50例(11.2%)转为干预,其中42例(84%)为腔内介入。
  • 汇总分析中保守治疗初始使用率为85.2%,成功率为84.7%,转为干预率为14.3%。
  • 抗血栓治疗组与未抗血栓组保守治疗失败率分别为17.8%和10.1%(p=0.103)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需开展大规模、前瞻性随机试验并进行长期随访以研究症状性SISMAD的治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the published treatment experience with symptomatic spontaneous isolated superior mesenteric artery dissection (SISMAD). METHODS: A literature search of the PubMed and Cochrane databases was conducted for articles on symptomatic SISMAD published in English from January 2007 to January 2018. Case series reporting on both treatment modalities and outcomes were included, while those on traumatic or iatrogenic SMA dissection or SMA dissection accompanied by aortic or other visceral artery dissection were excluded. Overall event rates for treated symptomatic SISMAD were calculated using pooled analyses. The rate of initial conservative treatment, the success rate, the rate of conversion to intervention, and the failure rate in patients with vs without antithrombotic therapy were calculated for each study and compared using a meta-analysis of proportions. RESULTS: The 25 articles selected encompassed 616 SISMAD cases, of which 514 were symptomatic cases eligible for the analysis. Among the latter, initial treatment consisted of conservative therapy in 447 (87.0%) patients and surgical interventions in 67 (13.0%) patients [45 (8.7%) endovascular procedures and 22 (4.3%) open surgeries]. Among conservative cases, 238 (53.2%) received antithrombotic therapy while 172 (38.5%) did not; 50 (11.2%) cases were converted to intervention [42 (84%) endovascular]. Conservative treatment was initially used in 85.2% of pooled cases with an 84.7% success rate, a 14.3% rate of conversion to intervention, and conservative treatment failure rates of 17.8% and 10.1% in patients treated with vs without antithrombotic therapy, respectively (p=0.103). CONCLUSION: Conservative treatment appeared safe and effective in >80% of symptomatic SISMAD cases, without apparent benefit for antithrombotic agent use. Initial or secondary intervention was more often endovascular, with favorable success rates and short-term outcomes. Large, prospective randomized trials with long-term follow-up are warranted on the treatment for symptomatic SISMAD.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zhu Y, Peng Y, Xu M, et al. Treatment Strategies and Outcomes of Symptomatic Spontaneous Isolated Superior Mesenteric Artery Dissection: A Systematic Review and Meta-analysis. J Endovasc Ther. 2018. PMID: 30153774. doi:10.1177/1526602818796537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。